The ESMO Preceptorship on Endometrial Cancer 2026 is a specialized educational course scheduled for July 1–2, 2026, in Lugano, Switzerland.

This intensive program is designed to provide medical oncologists with a comprehensive understanding of the multidisciplinary management of endometrial cancer, from diagnosis and pathology to advanced therapeutic strategies. Key learning objectives typically include exploring the “new” FIGO staging, the role of molecular classification in tailoring treatment, and the revolutionary impact of immunotherapy and combination therapies in recurrent or metastatic disease.

Application.